MCHUGH THOMAS S

Average Profitability
48.83%
Insider Buys Quantity
9
Insider Buys Sum
$432,836.67
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of MCHUGH THOMAS S

According to the SEC Form 4 filings, MCHUGH THOMAS S, being in a position of

  1. Chief Financial Officer at Avadel Pharmaceuticals plc,
    оver the last 12 months, has bought 9300 shares for $105,451, and sold 0 shares,
    over all time since 2020-08-13, has bought 87800 shares for $432,837, and sold 0 shares.

The largest purchase of all time was on 2022-05-27 and amounted to 50000 shares of Avadel Pharmaceuticals plc for $106,895.

Biography of MCHUGH THOMAS S

No biography is available at this moment.

2024-12-13PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Financial Officer
2,300
0.0024%
$10.44$24,019+1.25%
2024-12-11PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Financial Officer
5,000
0.0052%
$10.49$52,433+1.74%
2024-01-16PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Financial Officer
2,000
0.0021%
$14.50$29,000+3.04%
2023-08-14PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Financial Officer
2,000
0.0027%
$14.45$28,900+3.32%
2022-11-29PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Financial Officer
5,000
0.008%
$7.80$39,000+36.61%
2022-05-27PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Financial Officer
50,000
0.0724%
$2.14$106,895+179%
2020-09-18PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Financial Officer
4,000
0.007%
$6.00$24,000+28.91%
2020-08-28PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Financial Officer
7,500
0.0122%
$6.77$50,777+3.63%
2020-08-13PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Financial Officer
10,000
0.0173%
$7.78$77,814-4.02%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.